Exosomal transfer of HCC-derived miR-17-5p downregulates NK cell function by targeting RUNX1-NKG2D axis

Zhifeng Zhou1, Tianchuan Li2, Jieyu Li1

  • 1Laboratory of Immuno-Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, China; School of Basic Medical Sciences, Fujian Medical University, Fuzhu, Fujian, China.

Abstract

Insights

Hepatocellular Carcinoma (HCC) exosomes contain miR-17-5p, which targets RUNX1. This interaction suppresses NK cell activity against HCC, hindering anti-tumor immunity.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Natural killer (NK) cells are crucial for anti-tumor immunity within the tumor microenvironment.
  • MicroRNAs (miRNAs) regulate gene expression and influence NK cell development and function.
  • Hepatocellular Carcinoma (HCC) poses a significant health challenge, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To investigate the role of miR-17-5p in HCC exosomes in regulating NK cell cytotoxicity.
  • To elucidate the molecular mechanism involving the transcription factor RUNX1 and NKG2D.

Main Methods:

  • Exosomes were isolated from HCC tissues and cell lines.
  • miRNA profiling, qRT-PCR, and Western blotting were used for verification.
  • Luciferase reporter assays, ChIP, and in vitro/in vivo assays assessed molecular interactions and cellular functions.

Main Results:

  • miR-17-5p levels were elevated in HCC exosomes.
  • miR-17-5p directly targets RUNX1, which positively regulates NKG2D transcription.
  • Downregulation of RUNX1 and NKG2D by miR-17-5p impaired NK cell killing of HCC cells.

Conclusions:

  • miR-17-5p within HCC exosomes suppresses NK cell-mediated anti-tumor activity by targeting RUNX1.
  • This mechanism highlights a novel pathway for immune evasion in HCC.
  • Targeting miR-17-5p or its downstream effectors may represent a therapeutic approach for HCC.